Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance.

Background: The high fructose-fed rat is widely used as a model of insulin resistance. Genistein, a soy isoflavone, has been shown to improve insulin sensitivity in this model. The present study investigated whether genistein could prevent fatty liver disease in this model.